June 27, 2023
Taiho Pharmaceutical said on June 26 that its French partner Servier has received the backing of a key European regulatory panel for Lonsurf (trifluridine + tipiracil) in combination with bevacizumab for the third-line treatment of metastatic colorectal cancer (mCRC). The...read more